SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-002046
Filing Date
2020-01-07
Accepted
2020-01-07 17:31:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm201430d4_424b5.htm 424B5 279489
2 GRAPHIC lg_titan-pharma.jpg GRAPHIC 12900
  Complete submission text file 0001104659-20-002046.txt   298419
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-230742 | Film No.: 20514021
SIC: 2836 Biological Products, (No Diagnostic Substances)